Cardiovascular Journal of Africa: Vol 24 No 2 (March 2013)

11 / 67

CARDIOVASCULAR JOURNAL OF AFRICA • Vol 24, No 2, March 2013 AFRICA 9
References
1. Heeringa J, Kuip DVD, Hofman A, Kors J, Herpen GV, Stricker B,
et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the
Rotterdam study. Eur Heart J 2006; 27: 949–953.
2. Lloyd-Jones D, Wang T, Leip E, Larson M, Levy D, Vasan R, et al.
Lifetime risk for development of atrial fibrillation: the Framingham
Heart Study. Circulation 2004; 110(9): 1042–1046.
3. Crijns H, Camm J, Diener H, Goette A, Hindricks G, Hohnloser S,
et al. Outcome parameters for trials in atrial fibrillation: executive
summary. Recommendations from a consensus conference organized
by the German Atrial Fibrillation Competence Network (AFNET) and
the European Heart Rhythm Association (EHRA). Eur Heart J 2007;
28: 2803–2817.
4. Stewart S, Hart C, Hole D, McMurray J. A population-based study of
the long-term risks associated with atrial fibrillation: 20-year follow-up
of the Renfrew/Paisley study. Am J Med 2002; 113(5): 359–364.
5. Thrall G, Lane D, Carroll D, Lip G, et al . Quality of life in patients
with atrial fibrillation: a systematic review. Am J Med 2006; 119(5):
448.e1–e19.
6. Jamison D, Breman J, Measham A, Alleyne G, Claeson M, Evans D,
et al. Disease Control Priorities in Developing Countries. New York:
Oxford University, 2006.
7. Ntep-Gweth M, Zimmermann M, Meiltz A, Kingue S, Ndobo P, Urban
P, et al. Atrial fibrillation in Africa: clinical characteristics, prognosis,
and adherence to guidelines in Cameroon. Europace 2010; 12(4):
482–487.
8. Sliwa K, Carrington M, Klug E, Opie L, Lee G, Ball J, et al.
Predisposing factors and incidence of newly diagnosed atrial fibrilla-
tion in an urban African community: insights from the Heart of Soweto
Study. Heart 2010; 96(23): 1878–1882.
9. Gage B, Waterman AD, Shannon W, Boechler M, Rich M, Radford
M. Validation of clinical classification schemes for predicting stroke:
results from the National Registry of Atrial Fibrillation. J Am Med
Assoc 2001; 285: 2864–2870.
10. Healey J, Connolly S. Atrial fibrillation: hypertension as a causative
agent, risk factor for complications, and potential therapeutic target. Am
J Cardiol 2003; 91(10A): 9G–14G.
11. Eloi M, Phalla O, David C, Beatriz F, Ana O, Dinesh J, et al. Prevalence
of rheumatic heart disease detected by echocardiographic screening. N
Engl J Med 2007; 357: 470–476.
12. Anabwani G, Amoa A, Muita A. Epidemiology of rheumatic heart
disease among primary school children in western Kenya. Int J Cardiol
1989; 23(2): 249–252.
13. Lip G, Nieuwlaat R, Pisters R, Lane D, Crijns H. Refining clinical risk
stratification for predicting stroke and thromboembolism in atrial fibril-
lation using a novel risk factor-based approach: the euro heart survey on
atrial fibrillation. Chest 2010; 137: 263–272.
Contact :
BP : 6003 Dakar
Tél : (221) 33 821 55 21
(221) 33 889 38 00 Poste : 3900
Fax : (221) 33 822 47 46
Mail:
DAKAR